Cat.No.: | BSM-0188 |
Product Name: | ORY-1001 |
CAS No.: | 1431326-61-2 |
Figure: |
![]() |
Synonyms: | N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine, dihydrochloride; RG-6016 |
Description: | ORY-1001 is a potent and selective inhibitor of LSD1 (IC₅₀ < 20 nM). It targets acute myeloid leukemia (AML) stem cells and significantly reduces tumor cell load while increasing survival time in mouse models of AML. ORY-1001 is in clinical trials for cancer treatment. |
Appearance: | Crystalline solid |
Molecular Weight: | 303.27 |
Purity: | ≥98% by HPLC |
Storage: | -20°C |
Targets: | LSD1 |
Molecular Formula: | C₁₅H₂₄Cl₂N₂ |
MDL Number: | MFCD08705329 |
Solubility: | DMSO (~7 mg/ml) |
Shipping Conditions: | Gel Pack |
Warning: | For Research Use Only! Not For Use in Humans. |
Product Types | ||
◆ Research Kits | ||
EKIT-0062 | Histone Demethylase LSD1 Activity/Inhibition Assay Kit | Inquiry |
EKIT-0126 | LSD1 Inhibitor Screening Assay Kit | Inquiry |
EKIT-0160 | LSD1 Demethylase Activity/Inhibition Fluorometric Assay Kit | Inquiry |
◆ Bioactive Small Molecules | ||
BSM-0111 | DDP-38003 dihydrochloride | Inquiry |
BSM-0141 | GSK-LSD1 dihydrochloride | Inquiry |
Related Gene / Proteins | |||
LSD1 | LSD2 | LSM2 | LSM3 |
LSM5 | LSM6 | LSP1 |
USA
Enter your email here to subscribe.
Follow us on
Easy access to products and services you need from our library via powerful searching tools